RecruitingNot ApplicableNCT06465745
AltaValve Pivotal Trial
Sponsor
4C Medical Technologies, Inc.
Enrollment
450 participants
Start Date
Sep 3, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called AltaValve System. for people with mitral incompetence, mitral insufficiency, and other related conditions. The study is currently recruiting participants at 29 locations. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEAltaValve System.
Transcatheter Mitral Valve Replacement.
Locations(29)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06465745
Related Trials
Capstan Medical TMVR Study: FIH
NCT066001913 locations
A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System
NCT074509113 locations
Cephea Early Feasibility Study
NCT0506100422 locations
Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
NCT0549699837 locations
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
NCT0324264285 locations